Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 16541575 | Anti-TIGIT Antibodies | C07K, A61P, A61K | Aug 14, 2019 | Jan 5, 2021 |
| 16525131 | VARIANT TARGET BINDING AGENTS AND USES THEREOF | A61K, C07K | Jul 28, 2019 | Jun 29, 2022 |
| 16507839 | Monomethylvaline compounds capable of conjugation to ligands | A61K, C07K | Jul 9, 2019 | Oct 19, 2020 |
| 16452160 | Methods of inhibition of protein fucosylation in vivo using fucose analogs | A61P, A61K, C07K | Jun 24, 2019 | Jun 14, 2021 |
| 16414633 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | C07K, C12N, C07H | May 15, 2019 | May 2, 2022 |
| 16411867 | BCMA antibodies and use of same to treat cancer and immunological disorders | A61K, A61P, C07K | May 13, 2019 | Aug 2, 2021 |
| 16397331 | STABLE FORMULATIONS FOR ANTI-CD19 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES | A61J, C07K, A61K | Apr 28, 2019 | Apr 26, 2021 |
| 16381448 | Targeted pyrrolobenzodiazapine conjugates | A61K, C07D, C07K | Apr 10, 2019 | Feb 17, 2020 |
| 16376302 | CAMPTOTHECIN PEPTIDE CONJUGATES | A61P, A61K | Apr 4, 2019 | Jan 30, 2022 |
| 16375745 | Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates | A61K, C07K | Apr 3, 2019 | Nov 18, 2019 |
| 16362125 | Use of Antibody Drug Conjugates Comprising Tubulin Disrupting Agents to Treat Solid Tumor | A61K, A61P, C07K | Mar 21, 2019 | Nov 5, 2022 |
| 16968749 | Hydrophobic Auristatin F compounds and conjugates thereof | A61K | Feb 19, 2019 | Jan 1, 2024 |
| 16226509 | Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the PI3K-AKT mTOR pathway | A61K, A61P | Dec 18, 2018 | Mar 20, 2023 |
| 16768020 | HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF BREAST CANCER | C07K, A61K | Nov 29, 2018 | Apr 12, 2023 |
| 16768027 | Process for the preparation of drug linker compounds | C07D, A61K, C07K | Nov 28, 2018 | Mar 27, 2023 |
| 16203809 | CD47 antibodies and uses thereof for treating cancer | C07K, A61K, A61P | Nov 28, 2018 | Nov 22, 2021 |
| 16765059 | ACID-MEDIATED ASSAY FOR ANALYZING LIGAND-DRUG CONJUGATES | C07K, G01N | Nov 19, 2018 | |
| 16755091 | MODULATING THE IMMUNE RESPONSE USING ANTIBODY-DRUG CONJUGATES | C07K, A61K | Oct 10, 2018 | Jan 30, 2023 |
| 16755403 | Methods of reducing side effects of anti-CD30 antibody drug conjugate therapy | C07K, A61K, A61P | Oct 10, 2018 | Oct 23, 2023 |
| 16128363 | Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates | A61K, C07K | Sep 10, 2018 | Feb 8, 2021 |